- Learn More
We are fortunate to advise world-class, industry-leading companies, helping them tackle novel, complex issues and push the boundaries of technological progress. Our ability and confidence to go to trial is our core strength; our deep bench of experienced trial lawyers represents companies in their most significant matters, helping them protect their intellectual property and launch products. Our lawyers pair extensive experience in the courtroom and the boardroom with a thorough understanding of science and technology.
Litigation counsel Jennifer Gordon will speak at the Practising Law Institute’s upcoming conference on 2017 Developments in Pharmaceutical and Biotech Patent Law. Jennifer’s lecture, “The Evolving Law of Section 101 and Life Sciences Patents,” will survey Section 101 cases decided since Myriad and Mayo, discuss litigation and PTO trends, the timing of Section 101 challenges, and identifying the most vulnerable claims. The event will take place on November 1 in New York City.